206 related articles for article (PubMed ID: 16149978)
21. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
Hornung WP; Schonauer K; Feldmann R; Mönking HS
Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotics and the quality of life of schizophrenic patients.
Loga-Zec S; Loga S
Psychiatr Danub; 2010 Dec; 22(4):495-7. PubMed ID: 21169888
[TBL] [Abstract][Full Text] [Related]
23. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
24. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
[TBL] [Abstract][Full Text] [Related]
25. 'It's not my job. I'm the patient not the doctor': patient perspectives on medicines management in the treatment of schizophrenia.
Stewart DC; Anthony GB; Chesson R
Patient Educ Couns; 2010 Feb; 78(2):212-7. PubMed ID: 19665339
[TBL] [Abstract][Full Text] [Related]
26. Meeting everyday challenges: antipsychotic therapy in the real world.
Gorwood P
Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S156-62. PubMed ID: 16872807
[TBL] [Abstract][Full Text] [Related]
27. Depressed patients' preferences for education about medications by pharmacists in Kuwait.
Al-Saffar N; Abdulkareem A; Abdulhakeem A; Salah AQ; Heba M
Patient Educ Couns; 2008 Jul; 72(1):94-101. PubMed ID: 18337052
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
29. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
[TBL] [Abstract][Full Text] [Related]
30. Wanting to be heard: mental health consumers' experiences of information about medication.
Happell B; Manias E; Roper C
Int J Ment Health Nurs; 2004 Dec; 13(4):242-8. PubMed ID: 15660592
[TBL] [Abstract][Full Text] [Related]
31. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
32. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
Deurell M; Weischer M; Pagsberg AK; Labianca J
Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
[TBL] [Abstract][Full Text] [Related]
33. Sources of patients' knowledge of the adverse effects of psychotropic medication and the perceived influence of adverse effects on compliance among service users attending community mental health services.
Agyapong VI; Nwankwo V; Bangaru R; Kirrane R
J Clin Psychopharmacol; 2009 Dec; 29(6):565-70. PubMed ID: 19910722
[TBL] [Abstract][Full Text] [Related]
34. [Attitude of family to neuroleptics].
Angermeyer MC; Matschinger H
Psychiatr Prax; 1999 Jul; 26(4):171-4. PubMed ID: 10457968
[TBL] [Abstract][Full Text] [Related]
35. Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Hong Kong.
Lee S; Chiu MY; Tsang A; Chui H; Kleinman A
Soc Sci Med; 2006 Apr; 62(7):1685-96. PubMed ID: 16174547
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
Mallinger JB; Lamberti SJ
J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotics side effects' influence on stigma of mental illness: focus group study results.
Novak L; Svab V
Psychiatr Danub; 2009 Mar; 21(1):99-102. PubMed ID: 19270631
[TBL] [Abstract][Full Text] [Related]
39. Higher preference for participation in treatment decisions is associated with lower medication adherence in asthma patients.
Schneider A; Wensing M; Quinzler R; Bieber C; Szecsenyi J
Patient Educ Couns; 2007 Jul; 67(1-2):57-62. PubMed ID: 17346917
[TBL] [Abstract][Full Text] [Related]
40. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
